Dr. Reddy's Laboratories Limited (RDY)
NYSE: RDY · IEX Real-Time Price · USD
73.52
+1.20 (1.67%)
Mar 28, 2024, 9:58 AM EDT - Market open
Dr. Reddy's Laboratories Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Year | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 - 2001 |
---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 5,779 | 14,852 | 14,829 | 2,053 | 2,228 | 2,638 | 3,866 | 4,921 | 5,394 | 8,451 | Upgrade
|
Short-Term Investments | 56,018 | 29,513 | 19,744 | 23,687 | 22,529 | 18,330 | 14,270 | 35,034 | 34,259 | 25,083 | Upgrade
|
Cash & Cash Equivalents | 61,797 | 44,365 | 34,573 | 25,740 | 24,757 | 20,968 | 18,136 | 39,955 | 39,653 | 33,534 | Upgrade
|
Cash Growth | 39.29% | 28.32% | 34.32% | 3.97% | 18.07% | 15.62% | -54.61% | 0.76% | 18.25% | 51.74% | Upgrade
|
Receivables | 72,485 | 66,818 | 49,759 | 52,015 | 39,982 | 40,786 | 38,271 | 41,306 | 40,755 | 33,037 | Upgrade
|
Inventory | 48,670 | 50,884 | 45,412 | 35,066 | 33,579 | 29,089 | 28,529 | 25,578 | 25,529 | 23,992 | Upgrade
|
Other Current Assets | 23,988 | 19,789 | 18,505 | 17,549 | 16,183 | 18,802 | 15,439 | 12,849 | 13,901 | 13,184 | Upgrade
|
Total Current Assets | 206,940 | 181,856 | 148,249 | 130,370 | 114,501 | 109,645 | 100,375 | 119,688 | 119,838 | 103,747 | Upgrade
|
Property, Plant & Equipment | 66,462 | 62,169 | 57,111 | 52,332 | 54,088 | 57,869 | 57,160 | 53,961 | 48,090 | 44,424 | Upgrade
|
Long-Term Investments | 5,362 | 7,986 | 8,333 | 3,091 | 3,342 | 4,653 | 6,840 | 3,297 | 3,850 | 806 | Upgrade
|
Goodwill and Intangibles | 35,094 | 31,664 | 40,216 | 31,653 | 48,269 | 48,610 | 48,677 | 24,644 | 16,430 | 14,697 | Upgrade
|
Other Long-Term Assets | 7,996 | 9,152 | 11,582 | 14,795 | 5,227 | 4,827 | 6,769 | 6,060 | 6,554 | 6,549 | Upgrade
|
Total Long-Term Assets | 114,914 | 110,971 | 117,242 | 101,871 | 110,926 | 115,959 | 119,446 | 87,962 | 74,924 | 66,476 | Upgrade
|
Total Assets | 321,854 | 292,827 | 265,491 | 232,241 | 225,427 | 225,604 | 219,821 | 207,650 | 194,762 | 170,223 | Upgrade
|
Accounts Payable | 26,444 | 25,572 | 23,744 | 16,659 | 14,553 | 16,052 | 13,417 | 12,300 | 10,660 | 10,503 | Upgrade
|
Current Debt | 12,194 | 28,099 | 24,009 | 20,798 | 16,381 | 25,625 | 43,736 | 22,828 | 28,819 | 24,002 | Upgrade
|
Other Current Liabilities | 47,207 | 40,344 | 35,638 | 35,357 | 28,766 | 28,015 | 27,847 | 29,518 | 24,516 | 19,558 | Upgrade
|
Total Current Liabilities | 85,845 | 94,015 | 83,391 | 72,814 | 59,700 | 69,692 | 85,000 | 64,646 | 63,995 | 54,063 | Upgrade
|
Long-Term Debt | 1,278 | 5,746 | 6,299 | 1,304 | 22,000 | 25,089 | 5,449 | 10,685 | 14,307 | 20,740 | Upgrade
|
Other Long-Term Liabilities | 3,740 | 2,539 | 2,739 | 3,135 | 3,530 | 4,363 | 5,328 | 3,983 | 5,158 | 4,619 | Upgrade
|
Total Long-Term Liabilities | 5,018 | 8,285 | 9,038 | 4,439 | 25,530 | 29,452 | 10,777 | 14,668 | 19,465 | 25,359 | Upgrade
|
Total Liabilities | 90,863 | 102,300 | 92,429 | 77,253 | 85,230 | 99,144 | 95,777 | 79,314 | 83,460 | 79,422 | Upgrade
|
Total Debt | 13,472 | 33,845 | 30,308 | 22,102 | 38,381 | 50,714 | 49,185 | 33,513 | 43,126 | 44,742 | Upgrade
|
Debt Growth | -60.20% | 11.67% | 37.13% | -42.41% | -24.32% | 3.11% | 46.76% | -22.29% | -3.61% | 21.71% | Upgrade
|
Retained Earnings | 215,593 | 175,712 | 156,023 | 144,247 | 128,646 | 113,865 | 108,051 | 99,550 | 83,643 | 65,051 | Upgrade
|
Shareholders' Equity | 230,991 | 190,527 | 173,062 | 154,988 | 140,197 | 126,460 | 124,044 | 128,336 | 111,302 | 90,801 | Upgrade
|
Net Cash / Debt | 48,325 | 10,520 | 4,265 | 3,638 | -13,624 | -29,746 | -31,049 | 6,442 | -3,473 | -11,208 | Upgrade
|
Net Cash / Debt Growth | 359.36% | 146.66% | 17.23% | - | - | - | - | - | - | - | Upgrade
|
Net Cash Per Share | - | - | - | - | - | -178.99 | -185.92 | 37.66 | -20.32 | -65.66 | Upgrade
|
Working Capital | 121,095 | 87,841 | 64,858 | 57,556 | 54,801 | 39,953 | 15,375 | 55,042 | 55,843 | 49,684 | Upgrade
|
Book Value Per Share | 1387.95 | 1145.67 | 1041.46 | 933.29 | 845.01 | 762.52 | 744.34 | 752.49 | 653.51 | 533.98 | Upgrade
|
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).